SPRO logo

Spero Therapeutics (SPRO) Non Current Assets

Annual Non Current Assets

$51.18 M
+$39.95 M+355.68%

December 31, 2023


Summary


Performance

SPRO Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRObalance sheetmetrics:

Quarterly Non Current Assets

$3.53 M
-$24.13 M-87.22%

September 30, 2024


Summary


Performance

SPRO Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSPRObalance sheetmetrics:

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

SPRO Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+355.7%-93.1%
3 y3 years+257.8%-93.1%
5 y5 years+969.2%-93.1%

SPRO Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+355.7%-93.1%at low
5 y5-yearat high+378.8%-93.1%at low
alltimeall timeat high+4208.3%-93.1%+167.5%

Spero Therapeutics Non Current Assets History

DateAnnualQuarterly
Sep 2024
-
$3.53 M(-87.2%)
Jun 2024
-
$27.66 M(+0.4%)
Mar 2024
-
$27.55 M(-46.2%)
Dec 2023
$131.21 M(+15.5%)
$51.18 M(+949.0%)
Sep 2023
-
$4.88 M(-53.7%)
Jun 2023
-
$10.54 M(-3.2%)
Mar 2023
-
$10.88 M(-3.1%)
Dec 2022
$113.57 M(-28.1%)
$11.23 M(-3.1%)
Sep 2022
-
$11.59 M(-0.7%)
Jun 2022
-
$11.67 M(-11.1%)
Mar 2022
-
$13.13 M(-0.6%)
Dec 2021
$157.87 M(+13.5%)
$13.20 M(+2.2%)
Sep 2021
-
$12.92 M(-2.7%)
Jun 2021
-
$13.28 M(-4.8%)
Mar 2021
-
$13.95 M(-2.5%)
Dec 2020
$139.15 M
$14.31 M(-0.5%)
DateAnnualQuarterly
Sep 2020
-
$14.37 M(+17.2%)
Jun 2020
-
$12.26 M(+2.7%)
Mar 2020
-
$11.93 M(+11.6%)
Dec 2019
$95.41 M(-23.2%)
$10.69 M(+25.2%)
Sep 2019
-
$8.54 M(-12.8%)
Jun 2019
-
$9.80 M(+9.5%)
Mar 2019
-
$8.95 M(+86.9%)
Dec 2018
$124.22 M(+34.9%)
$4.79 M(+99.7%)
Sep 2018
-
$2.40 M(+14.1%)
Jun 2018
-
$2.10 M(+59.0%)
Mar 2018
-
$1.32 M(-7.0%)
Dec 2017
$92.06 M(+675.4%)
$1.42 M(-69.1%)
Sep 2017
-
$4.59 M(+75.0%)
Jun 2017
-
$2.62 M(+38.1%)
Dec 2016
$11.87 M(+98.3%)
$1.90 M
Dec 2015
$5.99 M
-

FAQ

  • What is Spero Therapeutics annual long term assets?
  • What is the all time high annual non current assets for Spero Therapeutics?
  • What is Spero Therapeutics annual non current assets year-on-year change?
  • What is Spero Therapeutics quarterly long term assets?
  • What is the all time high quarterly non current assets for Spero Therapeutics?
  • What is Spero Therapeutics quarterly non current assets year-on-year change?

What is Spero Therapeutics annual long term assets?

The current annual non current assets of SPRO is $51.18 M

What is the all time high annual non current assets for Spero Therapeutics?

Spero Therapeutics all-time high annual long term assets is $51.18 M

What is Spero Therapeutics annual non current assets year-on-year change?

Over the past year, SPRO annual long term assets has changed by +$39.95 M (+355.68%)

What is Spero Therapeutics quarterly long term assets?

The current quarterly non current assets of SPRO is $3.53 M

What is the all time high quarterly non current assets for Spero Therapeutics?

Spero Therapeutics all-time high quarterly long term assets is $51.18 M

What is Spero Therapeutics quarterly non current assets year-on-year change?

Over the past year, SPRO quarterly long term assets has changed by -$47.65 M (-93.10%)